Findings from these groups demonstrate that, while NTR operation slows tumor progression in mice, it is not sufficient to achieve CR alone, as opposed to groups receiving NTR+ CAR T cells (Figures 4A–4E). The gene discussed is NTSR1; the disease is neoplasm.